KLK7 and breast cancer: An analysis of tumors with the most recurrent outlier loss, ESR1, revealed concurrent upregulation of genes typically expressed in basal breast cancers, such as PROM1, KLK7, and NDRG1, suggesting a selection of a more basal-like phenotype in endocrine-resistant disease.